Caveats about early release of incomplete AIDS vaccine info

Ashton AIDS.pngWhile many news organizations breathlessly proclaimed a breakthrough - CBS called it a "big breakthrough" - about the news that aThailand trial showed a small protective effect of an experimental AIDS vaccine, some stories injected needed caveats.

David Brown of the Washington Post reminds readers that "The results were barely significant on statistical grounds." But he went on to write:

Other researchers were less sanguine about the study but did not want to be quoted by name as being skeptical when only a few details of the results have been released.


"I just think it's too early really," said one, who spoke on the condition of anonymity for that reason. "It is in a kind of gray zone, and I think we should really get the data and look at it and see what it all means."

About this Entry

This page contains a single entry by Gary Schwitzer published on September 25, 2009 7:56 AM.

BMJ papers conclude there's not enough evidence to support widespread PSA screening was the previous entry in this blog.

Reforming FDA medical device approval is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Archives

Pages

Wikio - Top of the Blogs - Health

Add to Technorati Favorites